EcoDrugPlus

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSACLG00000009026
Gene Symbol: LOC113013566
3 Cross references
250 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSACLG00000021255
Gene Symbol: SERPINC1
3 Cross references
202 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSACLG00000006478
Gene Symbol: LOC113032228
2 Cross references
387 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSACLG00000025457
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSACLG00000025129
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Protein Type 4 Subunit Alpha B-Like

Ensembl ID : ENSACLG00000018397
Gene Symbol: LOC113010049
3 Cross references
245 Possible Orthologues:

Sodium Channel, Voltage Gated, Type V-Like, Alpha B

Ensembl ID : ENSACLG00000019651
Gene Symbol: SCN5LAB
1 Cross references
246 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSACLG00000014075
Gene Symbol: SCN4A
1 Cross references
185 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSACLG00000003058
Gene Symbol: SCN8A
2 Cross references
218 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSACLG00000019145
Gene Symbol: LOC113025822
3 Cross references
241 Possible Orthologues:

Sodium/glucose Cotransporter 1-Like

Ensembl ID : ENSACLG00000019123
Gene Symbol: LOC113027317
3 Cross references
241 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1-Like

Ensembl ID : ENSACLG00000016283
Gene Symbol: LOC113016078
3 Cross references
273 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).